131![June 27, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation VIVUS gains MAA approval for TA-1790 in the EU June 27, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation VIVUS gains MAA approval for TA-1790 in the EU](https://www.pdfsearch.io/img/703af703468c1b105a6a9b57e603c902.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2013-06-27 01:00:46
|
---|
132![1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral u 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral u](https://www.pdfsearch.io/img/2092fd2e248025837417347ac8e99cf6.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-04-30 17:40:11
|
---|
133![Print IYH Cosmetic_Label_Eng.qxd Print IYH Cosmetic_Label_Eng.qxd](https://www.pdfsearch.io/img/2d6b9da9365a6735be087f29334822a5.jpg) | Add to Reading ListSource URL: www.hc-sc.gc.caLanguage: English - Date: 2013-06-24 14:19:21
|
---|
134![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS. Adempas (riociguat) tablets, for oral HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS. Adempas (riociguat) tablets, for oral](https://www.pdfsearch.io/img/864d7abb19e5bf2a3743e78598734174.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-05-09 14:51:40
|
---|
135![• HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRACEPT safely and effectively. See full prescribing information for VIRACEPT. • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRACEPT safely and effectively. See full prescribing information for VIRACEPT.](https://www.pdfsearch.io/img/c73e1f00625286b7d0cb1dfd7ad01058.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-06-04 11:53:45
|
---|
136![DIVISION OF BIOEQUIVALENCE REVIEW DIVISION OF BIOEQUIVALENCE REVIEW](https://www.pdfsearch.io/img/6a7a4fe2433dff52193ad78875c9f964.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
137![LEVITRA® (vardenafil HCl) TABLETS[removed]DESCRIPTION LEVITRA® (vardenafil HCl) TABLETS[removed]DESCRIPTION](https://www.pdfsearch.io/img/22facf30ad0c909d9a4b31f69c9d037a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:45:49
|
---|
138![CIALIS® 1 ANL 5215 AMP (tadalafil) CIALIS® 1 ANL 5215 AMP (tadalafil)](https://www.pdfsearch.io/img/0cad42fcfa35be1f7525eee8cbce2c45.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:45:47
|
---|
139![Pfizer Mechanism of Action PF[removed]PDE5 inhibitor Selective, competitive and reversible PDE5 inhibitor IUPHAR/BPS Guide to pharmacology: Pfizer Mechanism of Action PF[removed]PDE5 inhibitor Selective, competitive and reversible PDE5 inhibitor IUPHAR/BPS Guide to pharmacology:](https://www.pdfsearch.io/img/4b19e93a2cd16571b45323bbbeb12d39.jpg) | Add to Reading ListSource URL: www.ncats.nih.govLanguage: English - Date: 2014-05-12 12:58:36
|
---|
140![Ohio Department of Agriculture and Ohio Department of Health Governor John R. Kasich Ohio Department of Agriculture and Ohio Department of Health Governor John R. Kasich](https://www.pdfsearch.io/img/a6a168afd9a391f32635becc308ee4eb.jpg) | Add to Reading ListSource URL: www.agri.ohio.govLanguage: English - Date: 2014-05-29 09:21:59
|
---|